microLIQUID will be at Compamed 2018

Posted By J. Garcia / Sin categoría / No hay comentarios

microLIQUID will be pleasured to meet you at Compamed 2018 on November 12-15 in Düsseldorf. We will be at Hall 8a/F34.1.

 

OEM & ODM of Microfluidic Cartridges and Instruments, IVD & Bioscience and Cell Culture have been our main commitment areas over the last few years. With capabilities spanning the entire value chain, microLIQUID has become a one-stop provider of Bioscience solutions.

 

Starting with design and proof of concept, we work with our company partners from development to mass-production of potentially fully certified IVD or Pharma products.

 

We offer full solutions with capabilities to integrate different technologies in developments with a microfluidics core, becoming more than just a microfluidics company. Looking at our customers necessities, we have reinforced ourselves including a bioscience department, automated instrumentation and equipment, offering higher quality and faster services than the competence thanks to these resources.

 

We detected the need from the customer and we have evolved to offer the required complete service. Our OEM & ODM microfluidic cartridge technologies fit the demand for improving the efficiency of techniques applied in medical devices for diagnostics, drug delivery and drug discovery. Because of our focus in these sectors, we work on how our microfluidic technology could interface with and provide improvements for current workflows, assaying techniques etc.

 
At Compamed 2018, we would love to have an opportunity to demonstrate our latest offerings and technologies to you in depth as microLIQUID has grown over the last few months.

 

 

See you there!

 

Read More

World Osteoporosis Day: Developing a new Microfluidic POC System for early-stage osteoporosis detection

Posted By J. Garcia / Sin categoría / biotechnology, bone disease, diagnostic test, ivd, microfluidic technologies, microLIQUID, osteoporosis, PoCOsteo, point-of-care tool, porous bone / No hay comentarios

 

World Osteoporosis Day takes place every year on October 20.

 

Because of the ageing of the society, osteoporosis (literally “porous bone”) and its complications is becoming more and more prevalent, making the bone disease a health priority in many parts of the world.

 

Currently, osteoporosis is commonly known as a “silent killer” disease. Usually osteoporosis manifests itself in a drastic manner, i.e. through fracture of the osteoporotic bone in the affected individual. Until now little or no measures for prevention or early detection of this disease are taken, because no simple, yet sufficiently precise or sensitive tools for early detection of individuals at risk of osteoporosis are available, there is a need to develop a efficient rapid diagnostics test to detect the disease.

 

At microLIQUID we are proud to be able to help with our expertise in microfluidic IVD system development in this cause by being part of PoCOsteo. We are working hand in hand together with European leaders, both from academia and industry, to develop new  POC applications by using the latest microfluidic technologies applied to diagnostics.

 

The overall objective of the currently proposed PoCOsteo project is a IVD Point-of-care development. Also, the clinical validation and preparation for commercialization of thePoint-of-Care tool for bone disease. The osteoporosis prevention, osteoporosis detection and osteoporosis treatment is our aim.

 

Read More

WE ARE HIRING!

Posted By J. Garcia / Sin categoría / No hay comentarios

 

microLIQUID is on the hunt for experts. If you have the required experience for the following position, do not hesitate to contact us:

 

Production Programmer Technician

 

 

Read More

microLIQUID invites you to 2018 AACC Clinical Lab Expo (Chicago)

Posted By J. Garcia / Sin categoría / aacc, biotechnology, chicago, microfluidics / No hay comentarios

 

For another year, microLIQUID will be exhibiting at AACC 2018 (Annual Scientific Meeting & Clinical Lab Expo) which will take place at McCormick Place, Chicago, IL, USA (July 31-August 2).

 

On behalf of our company, if you are attending to the event, we want to take advantage to have a meeting with you in order to talk about our common interests.

 

You will be able to visit us at booth #1646 where we will be showcasing our latest offerings and technologies.

 

See you soon!

Read More

PoCOsteo, a new European effort targeting early-stage osteoporosis detection

Posted By J. Garcia / Sin categoría / No hay comentarios

 

microLIQUID has shown once again that it strives to develop new point-of-care platforms by using the latest technologies in microfluidics.

 

In this project, microLIQUID will be working together with European leaders, both from academia and industry, to develop new PoC applications.

 

We invite you to read the press release issued by Ghent University at the start of the project in October 2017.

 

 

                         

“Ghent, Belgium – October 1, 2017 – Ghent University and its project partners today announced the launch of the PoCOsteo project. Together they will develop and validate a point-of-care in-office device for identifying individuals at high risk of osteoporosis and osteoporotic fracture. The project is supported by the European Union’s Horizon 2020 Framework Programme for Industrial leadership in nanotechnologies, advanced materials, biotechnology and advanced manufacturing and processing (H2020-NMBP). The overall goal of the project is the development, clinical validation and preparation for commercialisation of a point-of-care tool for bone disease (a.o. osteoporosis) prevention, detection and treatment.

 

Indeed, as a consequence of the ageing of the society, osteoporosis (literally “porous bone”) and its complications is becoming more and more prevalent, making the bone disease a health priority in many parts of the world. Usually osteoporosis manifests itself in a drastic manner, i.e. through fracture of the osteoporotic bone in the affected individual. This causes a serious burden for the patient and a high medical care cost for the society. Currently osteoporosis is commonly known as a “silent killer” disease. Up to 20% of patients die in the first year following a hip fracture, mostly due to pre-existing medical conditions. Less than half of those who survive the hip fracture regain their previous level of function1. Early detection of individuals at risk of osteoporosis and starting a suitable treatment before fractures and complications arise would drastically improve the current situation. Until now little or no measures for prevention or early detection of osteoporosis are taken, because no simple, yet sufficiently accurate or sensitive tools for early detection are available.

 

The PoCOsteo system will employ electrochemical detection and brings together proteomics, genomics and microfluidics technologies. The in-office test will provide the results in real-time during consultation and can be performed by unskilled technicians even at rural areas where access to current state-of-the-art equipment is limited. The design will limit the amount of both expensive reagents and blood samples needed for the tests and so it not only reduces the cost of each test, which is of great importance, especially nowadays when full reimbursement is not practiced in many countries, but also reduces the patient’s pain and discomfort.

 

The project will be supported and advised by the IOF, the International Osteoporosis Foundation, which is the main global alliance of patient societies, research organizations, healthcare professionals and international companies working to promote bone, muscle and joint health.

 

Over the next four years, PoCOsteo will be coordinated by Ghent University. Industrial, academic and clinical partners will bring their expertise to the project: Universitat Rovira I Virgili and microLIQUID (Spain), Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung (Germany), Labman Automation (United Kingdom), Medizinische Universität Graz (Austria), Endocrinology and Metabolism Research Institute (Iran) and Fundico (Belgium).”

 

 

Read More

Nature Methods: Putting microfluidics in other people´s hands

Posted By J. Garcia / Sin categoría / No hay comentarios

 

In microfluidics, sharing is hard. However, practitioners are exploring new ways to share designs and devices along with their experience. Many thanks to Vivien Marx and Nature for giving microLIQUID the opportunity to describe our experience in Volume 15, Number 3 of the magazine NATURE.

 

Some of the key aspects of microLIQUID´s origins are set out in this review, as well as a description of our business model, which aims to manufacture new robust products and introduce them into the market.

 

Nature explains that microLIQUID was spun out of the technology centre IKERLAN in 2008. In microLIQUID´s first years, the customers were mainly academics requesting microfluidic chip development. Today, around 15% of microLIQUID customers are academics and R&D centres working with state-of-the-art technologies, and the rest are pharmaceutical and biotech companies, of which around 55% are in Europe and around 40% are in the U.S.. The review also points out that working with academics is essential for the future of the field because of the way it drives us toward next-generation solutions.

 

In 2013, the company switched from making stand-alone chips to designing and manufacturing microfluidic chips and automated instruments. This new value proposition reflects customer needs. It plays out well because it´s hard to launch a microfluidic device without knowing the automated instrumentation it will be associated with. This helps to explain why many microfluidic chips do not make it to market even after many years in development.

Read More

microLIQUID invites you to Analytica 2018

Posted By J. Garcia / Sin categoría / No hay comentarios

microLIQUID will be at Analytica 2018 this April 09-13 in München, Germany.

 

On behalf of our company, if you are attending to the event, we want to take advantage  to have a meeting with you in order to talk about our common interests.

 

We will be pleased to invite you to join us at our stand A3.220,  where we will be showcasing our latest offerings and technologies, and we will have our top product experts on hand to answer your questions.

 

Looking forward to seeing you.

 

Read More

microLIQUID will be present in different fairs during 2018!

Posted By J. Garcia / Sin categoría / No hay comentarios

 

microLIQUID is pleased to announce that we will be exhibiting at several international events during this year. See some of them below:

 

Analytica is the International Trade Fair for Laboratory Technology, Analysis and Biotechnology.

 

 

  •  For another year, microLIQUID will be exhibiting at AACC 2018 (Annual Scientific Meeting & Clinical Lab Expo) which will take place at McCormick Place, Chicago, IL, USA (July 29-August 2).  You will be able to visit us at Booth #1646.

The 70th AACC Annual Scientific Meeting & Clinical Lab Expo is the largest global scientific conference
and tradeshow in the field of laboratory medicine.

 

 

  • After the success of earlier events, we will be renewing our participation in Compamed 2018. This fair will be held in Messe Düsseldorf, Düsseldorf, Germany (November 12-15). We will be in Hall 8a/F34.1.
 
Compamed is the international trade fair for the medical supplier industry and product development.

 

 

We will be demonstrating our latest offerings and technologies and we will have our top product experts on hand to answer your questions. Therefore, don´t hesitate to send us an  e-mail to [email protected] if you are interested in scheduling a meeting with one of our experts on site.

Read More

WE ARE HIRING!

Posted By J. Garcia / Sin categoría / biotechnology, microfluidic, microfluidic chip / No hay comentarios

 

microLIQUID is on the hunt for experts. If you have the required experience for any of the following positions, do not hesitate to contact us at [email protected]:

 

Electronic Engineer

 

Fabrication Process Developer for Microfluidic Products

Read More

Point-of-Care Diagnostics and Microfluidics

Posted By J. Garcia / Sin categoría / biotechnology, microfluidic, microfluidic chip / No hay comentarios

We invite you to have a look at our new video that was recorded during Compamed 2017; where our CTO Luis Fernández

talks about the future of Point-of-Care,Drug Delivery and Microfluidic Technologies.

 

Read More

where are we?